Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Lancet Market

ID: MRFR/MED/1546-CR
106 Pages
Satyendra Maurya
Last Updated: May 15, 2026

Lancet Market Research Report Information by Type (Safety Lancet, Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet, and Personal Lancet), By End Users (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, and Research and Academic Laboratories), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Lancet Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Safety Lancet
  50.     4.1.2 Push Button Safety Lancet
  51.     4.1.3 Pressure Activated Safety Lancet
  52.     4.1.4 Side Button Safety Lancet
  53.     4.1.5 Personal Lancet
  54.   4.2 Healthcare, BY End User (USD Billion)
  55.     4.2.1 Hospitals & Clinics
  56.     4.2.2 Diagnostic Centers and Pathology Laboratories
  57.     4.2.3 Home Diagnostics
  58.     4.2.4 Research and Academic Laboratories
  59.   4.3 Healthcare, BY Region (USD Billion)
  60.     4.3.1 North America
  61.       4.3.1.1 US
  62.       4.3.1.2 Canada
  63.     4.3.2 Europe
  64.       4.3.2.1 Germany
  65.       4.3.2.2 UK
  66.       4.3.2.3 France
  67.       4.3.2.4 Russia
  68.       4.3.2.5 Italy
  69.       4.3.2.6 Spain
  70.       4.3.2.7 Rest of Europe
  71.     4.3.3 APAC
  72.       4.3.3.1 China
  73.       4.3.3.2 India
  74.       4.3.3.3 Japan
  75.       4.3.3.4 South Korea
  76.       4.3.3.5 Malaysia
  77.       4.3.3.6 Thailand
  78.       4.3.3.7 Indonesia
  79.       4.3.3.8 Rest of APAC
  80.     4.3.4 South America
  81.       4.3.4.1 Brazil
  82.       4.3.4.2 Mexico
  83.       4.3.4.3 Argentina
  84.       4.3.4.4 Rest of South America
  85.     4.3.5 MEA
  86.       4.3.5.1 GCC Countries
  87.       4.3.5.2 South Africa
  88.       4.3.5.3 Rest of MEA
  89. 5 SECTION V: COMPETITIVE ANALYSIS
  90.   5.1 Competitive Landscape
  91.     5.1.1 Overview
  92.     5.1.2 Competitive Analysis
  93.     5.1.3 Market share Analysis
  94.     5.1.4 Major Growth Strategy in the Healthcare
  95.     5.1.5 Competitive Benchmarking
  96.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  97.     5.1.7 Key developments and growth strategies
  98.       5.1.7.1 New Product Launch/Service Deployment
  99.       5.1.7.2 Merger & Acquisitions
  100.       5.1.7.3 Joint Ventures
  101.     5.1.8 Major Players Financial Matrix
  102.       5.1.8.1 Sales and Operating Income
  103.       5.1.8.2 Major Players R&D Expenditure. 2023
  104.   5.2 Company Profiles
  105.     5.2.1 Roche (CH)
  106.       5.2.1.1 Financial Overview
  107.       5.2.1.2 Products Offered
  108.       5.2.1.3 Key Developments
  109.       5.2.1.4 SWOT Analysis
  110.       5.2.1.5 Key Strategies
  111.     5.2.2 Abbott (US)
  112.       5.2.2.1 Financial Overview
  113.       5.2.2.2 Products Offered
  114.       5.2.2.3 Key Developments
  115.       5.2.2.4 SWOT Analysis
  116.       5.2.2.5 Key Strategies
  117.     5.2.3 Siemens Healthineers (DE)
  118.       5.2.3.1 Financial Overview
  119.       5.2.3.2 Products Offered
  120.       5.2.3.3 Key Developments
  121.       5.2.3.4 SWOT Analysis
  122.       5.2.3.5 Key Strategies
  123.     5.2.4 Thermo Fisher Scientific (US)
  124.       5.2.4.1 Financial Overview
  125.       5.2.4.2 Products Offered
  126.       5.2.4.3 Key Developments
  127.       5.2.4.4 SWOT Analysis
  128.       5.2.4.5 Key Strategies
  129.     5.2.5 Becton Dickinson (US)
  130.       5.2.5.1 Financial Overview
  131.       5.2.5.2 Products Offered
  132.       5.2.5.3 Key Developments
  133.       5.2.5.4 SWOT Analysis
  134.       5.2.5.5 Key Strategies
  135.     5.2.6 Danaher (US)
  136.       5.2.6.1 Financial Overview
  137.       5.2.6.2 Products Offered
  138.       5.2.6.3 Key Developments
  139.       5.2.6.4 SWOT Analysis
  140.       5.2.6.5 Key Strategies
  141.     5.2.7 PerkinElmer (US)
  142.       5.2.7.1 Financial Overview
  143.       5.2.7.2 Products Offered
  144.       5.2.7.3 Key Developments
  145.       5.2.7.4 SWOT Analysis
  146.       5.2.7.5 Key Strategies
  147.     5.2.8 Sysmex (JP)
  148.       5.2.8.1 Financial Overview
  149.       5.2.8.2 Products Offered
  150.       5.2.8.3 Key Developments
  151.       5.2.8.4 SWOT Analysis
  152.       5.2.8.5 Key Strategies
  153.     5.2.9 Mindray (CN)
  154.       5.2.9.1 Financial Overview
  155.       5.2.9.2 Products Offered
  156.       5.2.9.3 Key Developments
  157.       5.2.9.4 SWOT Analysis
  158.       5.2.9.5 Key Strategies
  159.   5.3 Appendix
  160.     5.3.1 References
  161.     5.3.2 Related Reports
  162. 6 LIST OF FIGURES
  163.   6.1 MARKET SYNOPSIS
  164.   6.2 NORTH AMERICA MARKET ANALYSIS
  165.   6.3 US MARKET ANALYSIS BY TYPE
  166.   6.4 US MARKET ANALYSIS BY END USER
  167.   6.5 CANADA MARKET ANALYSIS BY TYPE
  168.   6.6 CANADA MARKET ANALYSIS BY END USER
  169.   6.7 EUROPE MARKET ANALYSIS
  170.   6.8 GERMANY MARKET ANALYSIS BY TYPE
  171.   6.9 GERMANY MARKET ANALYSIS BY END USER
  172.   6.10 UK MARKET ANALYSIS BY TYPE
  173.   6.11 UK MARKET ANALYSIS BY END USER
  174.   6.12 FRANCE MARKET ANALYSIS BY TYPE
  175.   6.13 FRANCE MARKET ANALYSIS BY END USER
  176.   6.14 RUSSIA MARKET ANALYSIS BY TYPE
  177.   6.15 RUSSIA MARKET ANALYSIS BY END USER
  178.   6.16 ITALY MARKET ANALYSIS BY TYPE
  179.   6.17 ITALY MARKET ANALYSIS BY END USER
  180.   6.18 SPAIN MARKET ANALYSIS BY TYPE
  181.   6.19 SPAIN MARKET ANALYSIS BY END USER
  182.   6.20 REST OF EUROPE MARKET ANALYSIS BY TYPE
  183.   6.21 REST OF EUROPE MARKET ANALYSIS BY END USER
  184.   6.22 APAC MARKET ANALYSIS
  185.   6.23 CHINA MARKET ANALYSIS BY TYPE
  186.   6.24 CHINA MARKET ANALYSIS BY END USER
  187.   6.25 INDIA MARKET ANALYSIS BY TYPE
  188.   6.26 INDIA MARKET ANALYSIS BY END USER
  189.   6.27 JAPAN MARKET ANALYSIS BY TYPE
  190.   6.28 JAPAN MARKET ANALYSIS BY END USER
  191.   6.29 SOUTH KOREA MARKET ANALYSIS BY TYPE
  192.   6.30 SOUTH KOREA MARKET ANALYSIS BY END USER
  193.   6.31 MALAYSIA MARKET ANALYSIS BY TYPE
  194.   6.32 MALAYSIA MARKET ANALYSIS BY END USER
  195.   6.33 THAILAND MARKET ANALYSIS BY TYPE
  196.   6.34 THAILAND MARKET ANALYSIS BY END USER
  197.   6.35 INDONESIA MARKET ANALYSIS BY TYPE
  198.   6.36 INDONESIA MARKET ANALYSIS BY END USER
  199.   6.37 REST OF APAC MARKET ANALYSIS BY TYPE
  200.   6.38 REST OF APAC MARKET ANALYSIS BY END USER
  201.   6.39 SOUTH AMERICA MARKET ANALYSIS
  202.   6.40 BRAZIL MARKET ANALYSIS BY TYPE
  203.   6.41 BRAZIL MARKET ANALYSIS BY END USER
  204.   6.42 MEXICO MARKET ANALYSIS BY TYPE
  205.   6.43 MEXICO MARKET ANALYSIS BY END USER
  206.   6.44 ARGENTINA MARKET ANALYSIS BY TYPE
  207.   6.45 ARGENTINA MARKET ANALYSIS BY END USER
  208.   6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  209.   6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  210.   6.48 MEA MARKET ANALYSIS
  211.   6.49 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  212.   6.50 GCC COUNTRIES MARKET ANALYSIS BY END USER
  213.   6.51 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  214.   6.52 SOUTH AFRICA MARKET ANALYSIS BY END USER
  215.   6.53 REST OF MEA MARKET ANALYSIS BY TYPE
  216.   6.54 REST OF MEA MARKET ANALYSIS BY END USER
  217.   6.55 KEY BUYING CRITERIA OF HEALTHCARE
  218.   6.56 RESEARCH PROCESS OF MRFR
  219.   6.57 DRO ANALYSIS OF HEALTHCARE
  220.   6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  221.   6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  222.   6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
  223.   6.61 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  224.   6.62 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  225.   6.63 HEALTHCARE, BY END USER, 2024 (% SHARE)
  226.   6.64 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  227.   6.65 BENCHMARKING OF MAJOR COMPETITORS
  228. 7 LIST OF TABLES
  229.   7.1 LIST OF ASSUMPTIONS
  230.     7.1.1
  231.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  232.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  233.     7.2.2 BY END USER, 2025-2035 (USD Billion)
  234.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  235.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  236.     7.3.2 BY END USER, 2025-2035 (USD Billion)
  237.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  238.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  239.     7.4.2 BY END USER, 2025-2035 (USD Billion)
  240.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  241.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  242.     7.5.2 BY END USER, 2025-2035 (USD Billion)
  243.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  244.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  245.     7.6.2 BY END USER, 2025-2035 (USD Billion)
  246.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  247.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  248.     7.7.2 BY END USER, 2025-2035 (USD Billion)
  249.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  250.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  251.     7.8.2 BY END USER, 2025-2035 (USD Billion)
  252.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  253.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  254.     7.9.2 BY END USER, 2025-2035 (USD Billion)
  255.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  256.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  257.     7.10.2 BY END USER, 2025-2035 (USD Billion)
  258.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  259.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  260.     7.11.2 BY END USER, 2025-2035 (USD Billion)
  261.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  262.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  263.     7.12.2 BY END USER, 2025-2035 (USD Billion)
  264.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  265.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  266.     7.13.2 BY END USER, 2025-2035 (USD Billion)
  267.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  268.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  269.     7.14.2 BY END USER, 2025-2035 (USD Billion)
  270.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  271.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  272.     7.15.2 BY END USER, 2025-2035 (USD Billion)
  273.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  274.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  275.     7.16.2 BY END USER, 2025-2035 (USD Billion)
  276.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  277.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  278.     7.17.2 BY END USER, 2025-2035 (USD Billion)
  279.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  280.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  281.     7.18.2 BY END USER, 2025-2035 (USD Billion)
  282.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  283.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  284.     7.19.2 BY END USER, 2025-2035 (USD Billion)
  285.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  286.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  287.     7.20.2 BY END USER, 2025-2035 (USD Billion)
  288.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  289.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  290.     7.21.2 BY END USER, 2025-2035 (USD Billion)
  291.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  292.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  293.     7.22.2 BY END USER, 2025-2035 (USD Billion)
  294.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  295.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  296.     7.23.2 BY END USER, 2025-2035 (USD Billion)
  297.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  298.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  299.     7.24.2 BY END USER, 2025-2035 (USD Billion)
  300.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  301.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  302.     7.25.2 BY END USER, 2025-2035 (USD Billion)
  303.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  304.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  305.     7.26.2 BY END USER, 2025-2035 (USD Billion)
  306.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  307.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  308.     7.27.2 BY END USER, 2025-2035 (USD Billion)
  309.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  310.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  311.     7.28.2 BY END USER, 2025-2035 (USD Billion)
  312.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  313.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  314.     7.29.2 BY END USER, 2025-2035 (USD Billion)
  315.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  316.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  317.     7.30.2 BY END USER, 2025-2035 (USD Billion)
  318.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  319.     7.31.1
  320.   7.32 ACQUISITION/PARTNERSHIP
  321.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Safety Lancet
  • Push Button Safety Lancet
  • Pressure Activated Safety Lancet
  • Side Button Safety Lancet
  • Personal Lancet

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals & Clinics
  • Diagnostic Centers and Pathology Laboratories
  • Home Diagnostics
  • Research and Academic Laboratories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions